Obi Pharma Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Obi Pharma Inc with three other
companies in this sector in TAIWAN :
sales of 101.35 million Taiwanese Dollars [US$3.64 million]
(91.81 million Taiwanese Dollars [US$3.30 million]
of which 40%
was Medical Appliance), and
Taiwan Liposome Co Limited
(101.93 million Taiwanese Dollars [US$3.66 million]
of which 56%
was Authorized cooperative development incom).